Newsletter | May 11, 2023

05.11.23 -- How Can Life Sciences Navigate M&A In 2023
 
Sponsor
Featured Editorial
How Can Life Sciences Navigate M&A In 2023?
 
By Arda Ural, Ph.D., EY

As we close out the first quarter of 2023, let's take a look at how life sciences executives can conduct better M&A deals despite this unpredictable business environment.
Increase In FDA Inspections + Whistleblower Complaints = Heightened Compliance Scrutiny
 
By A. Noorani, C. Fanelli, D. Ludlow, and R. Pai, Sidley Austin LLP

We are seeing a significant increase in manufacturing facility inspections by the FDA and other health authorities globally. We are also seeing an uptick in whistleblower complaints. Why? And how can you navigate it? This article examines the issue.
Industry Insights
Taking Charge Of Your Stability Program
White Paper | By P. Hamill, Ph.D., A. Glekas, Ph.D., and G. Pirozzi, Ph.D., MilliporeSigma Biosafety Testing Services

Learn how consolidating stability testing with a single partner offers improved efficiency, reduced risk, and more.
The Importance Of An Analytical Testing Strategy
White Paper | West Pharmaceutical Services, Inc.

A proper and well thought out combination product testing strategy, rooted in applicable guidances in sync with scientifically sound methods, data capture, reporting, and retainment, is critical.
Integrated Systems For Sophisticated Drug Device Combination Products
Q&A | BD Medical - Pharmaceutical Systems

In this interview, experts discuss the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems, and the crucial role a partner can play as systems integrator.
Sponsor
News Headlines
Solutions
Is Evaporation Important For Optical Biosensors?
Cytiva
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.